Tumor-infiltrating lymphocytes (TILs) from patients with glioma
Tumor-infiltrating lymphocytes (TILs) may represent a viable source of T cells for the biological treatment of patients with gliomas. Glioma tissue was obtained from 16 patients, tumor cell lines were established, and TILs were expanded in 16/16 cases using a combination of IL-2/IL-15/IL-21. Intrace...
Main Authors: | Zhenjiang Liu, Qingda Meng, Jiri Bartek, Thomas Poiret, Oscar Persson, Lalit Rane, Elena Rangelova, Christopher Illies, Inti Harvey Peredo, Xiaohua Luo, Martin Vijayakumar Rao, Rebecca Axelsson Robertson, Ernest Dodoo, Markus Maeurer |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-02-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/2162402X.2016.1252894 |
Similar Items
-
Takk til fagfeller
by: Ingri Løkholm Ramberg, et al.
Published: (2020-12-01) -
Comparative Study on the Larvicidal Activity of Drimane Sesquiterpenes and Nordrimane Compounds against Drosophila melanogaster til-til
by: Mauricio Cuellar, et al.
Published: (2013-04-01) -
Epstein–Barr virus- and cytomegalovirus-specific immune response in patients with brain cancer
by: Zhenjiang Liu, et al.
Published: (2018-07-01) -
Mesothelin-specific Immune Responses Predict Survival of Patients With Brain Metastasis
by: Liu Zhenjiang, et al.
Published: (2017-09-01) -
The association between CD3+ and CD8+tumor-infiltrating lymphocytes (TILs) and prognosis in patients with pancreatic adenocarcinoma
by: Mahshid Panahi, et al.
Published: (2023-01-01)